Scientists at the University of British Columbia are studying the effects of a common antibiotic, Ceftriaxone, on cell communication networks in the brains of rats with Alzheimer’s disease. While the research is still very preliminary, the researchers are hopeful that this finding may unlock new pathways to target in treating the disease at early stages.
Learn more here at Science Daily
–
英屬哥倫比亞大學的科學家正研究一款名為頭孢曲鬆(Ceftriaxone)的普通抗生素，通過用患有阿爾茨海默病的大鼠為實驗對象，了解頭孢曲鬆對腦細胞通訊網絡的影響。 儘管研究仍然非常初步，研究人員希望這一發現可以開啟新的治療方式，並用於阿爾茨海默病的早期治療。